Alcresta Therapeutics Receives New Innovative Technology Contract from Vizient, Inc. For RELiZORB® (iMMOBILIZED LIPASE) Cartridge

_DSC0439

A recent clinical publication in the Journal of Pediatric Gastroenterology and Nutrition demonstrated the efficacy and safety of RELiZORB use in correcting deficiencies of healthy fats that are often observed in patients receiving enteral nutrition …

Read more